South Western Railway One Year After Nationalisation Progress and Reliability Questions Linger Japans Landmark Intelligence Reform Implications for National Security and Defense Sector DeepSeek AI Model Triggers SafeHaven Flows Yen and Swiss Franc Strengthen Against Dollar Indias Gen Z Protests and Website Shutdown Highlight Rising Political Risk for Investors US Productivity Growth Eases in Q4 While Unit Labor Costs Accelerate SP 500 Mildly Higher as Healthcare and Tech Lead Communication Services Drag MGRC Q1 2026 Earnings EPS Falls Short of Estimates Shares Inch Higher UNF Q1 2026 Earnings Earnings Beat Expectations as EPS Surpasses Estimates PEG Q1 2026 Earnings Earnings Beat Estimates Despite Slight Stock Decline JOE Q1 2026 Earnings EPS of 024 Reported Stock Sees Slight Decline CeriBell Inc CBLL Q1 2026 Earnings EPS Misses Estimates by 307 Stock Edges Higher ADBE Q1 2026 Earnings EPS Tops Estimates Modestly Dogness DOGZ Rebounds Approaching Key Resistance After 294 Gain RWAYL Shows Minimal Movement as FixedIncome Investors Focus on Yield Stability CarPartscom PRTS Holds Steady Near Support Levels as Modest Uptick Signals Caution CleanSpark CLSK Shows Strength as Shares Climb 276 to 1620 Amid Broader Crypto Momentum InflaRx NV IFRX Tumbles 684 as Shares Test Key Support at 226 Ryanair Posts Record Annual Profit of 226 Billion Amid Boeing Delivery Delays and Fuel Market Uncertainty GILT Q1 2026 Earnings Massive EPS Surprise of 341 Despite Negative Market Reaction SEBI Proposes Overhaul of IPO Price Discovery Mechanism Amid Distortion Concerns Trinity Capital Inc 7875 Notes due 2029 TRINZ Q1 2026 Earnings Modest EPS Beat Meets Subdued Market Reaction SpaceX Delays Starship V3 Test Flight Rescheduled for Friday Amid MultiBillion Dollar Development China Prepares Humanoid Robots for Employment as Part of Industrial Strategy TikTok and YouTube Face Scrutiny Over Child Safety Standards by UK Regulator Ofcom Black Diamond Therapeutics BDTX Q1 2026 Earnings EPS Beat Fails to Lift Stock as Pipeline Uncertainty Lingers CytoMed Therapeutics GDTC Drops 738 Key Support Levels in Focus Amid Selling Pressure